Last reviewed · How we verify

Fentanyl citrate; Naltrexone; Naloxone

Alza Corporation, DE, USA · Phase 1 active Small molecule

Fentanyl citrate; Naltrexone; Naloxone is a Small molecule drug developed by Alza Corporation, DE, USA. It is currently in Phase 1 development.

At a glance

Generic nameFentanyl citrate; Naltrexone; Naloxone
SponsorAlza Corporation, DE, USA
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fentanyl citrate; Naltrexone; Naloxone

What is Fentanyl citrate; Naltrexone; Naloxone?

Fentanyl citrate; Naltrexone; Naloxone is a Small molecule drug developed by Alza Corporation, DE, USA.

Who makes Fentanyl citrate; Naltrexone; Naloxone?

Fentanyl citrate; Naltrexone; Naloxone is developed by Alza Corporation, DE, USA (see full Alza Corporation, DE, USA pipeline at /company/alza-corporation-de-usa).

What development phase is Fentanyl citrate; Naltrexone; Naloxone in?

Fentanyl citrate; Naltrexone; Naloxone is in Phase 1.

Related